Lamya Karim1, Taraneh Rezaee2, Rachana Vaidya2. 1. Department of Bioengineering, University of Massachusetts Dartmouth, 285 Old Westport Road, Dartmouth, MA, 02747, USA. lkarim@umassd.edu. 2. Department of Bioengineering, University of Massachusetts Dartmouth, 285 Old Westport Road, Dartmouth, MA, 02747, USA.
Abstract
PURPOSE OF REVIEW: There is ample evidence that patients with type 2 diabetes (T2D) have increased risk of fracture even though they have normal or high bone mineral density. As a result, poor bone quality is suggested to contribute to skeletal fragility in this population. Thus, our goal was to conduct a comprehensive literature review to understand how bone quality components are altered in T2D and their effects on bone biomechanics and fracture risk. RECENT FINDINGS: T2D does affect bone quality via alterations in bone microarchitecture, organic matrix, and cellular behavior. Further, studies indicate that bone biomechanical properties are generally deteriorated in T2D, but there are few reports in patients. Additional work is needed to better understand molecular and cellular mechanisms that contribute to skeletal fragility in T2D. This knowledge can contribute to the development of improved diagnostic tools and drug targets to for improved quality of life for those with T2D.
PURPOSE OF REVIEW: There is ample evidence that patients with type 2 diabetes (T2D) have increased risk of fracture even though they have normal or high bone mineral density. As a result, poor bone quality is suggested to contribute to skeletal fragility in this population. Thus, our goal was to conduct a comprehensive literature review to understand how bone quality components are altered in T2D and their effects on bone biomechanics and fracture risk. RECENT FINDINGS: T2D does affect bone quality via alterations in bone microarchitecture, organic matrix, and cellular behavior. Further, studies indicate that bone biomechanical properties are generally deteriorated in T2D, but there are few reports in patients. Additional work is needed to better understand molecular and cellular mechanisms that contribute to skeletal fragility in T2D. This knowledge can contribute to the development of improved diagnostic tools and drug targets to for improved quality of life for those with T2D.
Entities:
Keywords:
Biomechanics; Bone; Bone matrix; Non-enzymatic glycation; Skeletal fragility; Type 2 diabetes
Authors: Denise E Bonds; Joseph C Larson; Ann V Schwartz; Elsa S Strotmeyer; John Robbins; Beatriz L Rodriguez; Karen C Johnson; Karen L Margolis Journal: J Clin Endocrinol Metab Date: 2006-06-27 Impact factor: 5.958
Authors: Ofri Mosenzon; Cheryl Wei; Jaime Davidson; Benjamin M Scirica; Ilan Yanuv; Aliza Rozenberg; Boaz Hirshberg; Avivit Cahn; Christina Stahre; Krzysztof Strojek; Deepak L Bhatt; Itamar Raz Journal: Diabetes Care Date: 2015-09-10 Impact factor: 19.112
Authors: Julien Paccou; Kate A Ward; Karen A Jameson; Elaine M Dennison; Cyrus Cooper; Mark H Edwards Journal: Calcif Tissue Int Date: 2015-12-19 Impact factor: 4.333
Authors: Nelson B Watts; John P Bilezikian; Keith Usiskin; Robert Edwards; Mehul Desai; Gordon Law; Gary Meininger Journal: J Clin Endocrinol Metab Date: 2015-11-18 Impact factor: 5.958
Authors: David Zeitoun; Guavri Caliaperoumal; Morad Bensidhoum; Jean Marc Constans; Fani Anagnostou; Valérie Bousson Journal: Eur Radiol Exp Date: 2019-04-11